Sruti Shiva

Sruti Shiva

Auto-generated profile, based on publicly available information

Sruti Shiva

Vascular Medicine Institute, USA; Division of Classical Hematology, Department of Medicine, USA; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh School of Medicine, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Redox Biology
Verified
Journal Article
Open access
DNDeirdre Nolfi-Donegan
Deirdre Nolfi-Donegan
ABAndrea Braganza
Andrea Braganza
SSSruti Shiva
Sruti Shiva
The mitochondrial electron transport chain utilizes a series of electron transfer reactions to generate cellular ATP through oxidative phosphorylation. A consequence of electron transfer is the generation of reactive oxygen species (ROS), which contributes to both homeostatic signaling as well as oxidative stress during pathology. In this graphical review we provide an overview of oxidative phosphorylation and its inter-relationship with ROS production by the electron transport chain. We also outline traditional and novel translational methodology for assessing mitochondrial energetics in health and disease.

1 March 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
JRJason J. Rose
Jason J. Rose
LWLing Wang
Ling Wang
QXQinzi Xu
Qinzi Xu
CMCharles F. McTiernan
Charles F. McTiernan
SSSruti Shiva
Sruti Shiva
MGMark T. Gladwin
Mark T. Gladwin
Carbon monoxide (CO) poisoning affects 50,000 people a year in the United States. The clinical presentation runs a spectrum, ranging from headache and dizziness to coma and death, with a mortality rate ranging from 1 to 3%. A significant number of patients who survive CO poisoning suffer from long-term neurological and affective sequelae. The neurologic deficits do not necessarily correlate with blood CO levels but likely result from the pleiotropic effects of CO on cellular mitochondrial respiration, cellular energy utilization, inflammation, and free radical generation, especially in the brain and heart. Long-term neurocognitive deficits occur in 15–40% of patients, whereas approximately one-third of moderate to severely poisoned patients exhibit cardiac dysfunction, including arrhythmia, left ventricular systolic dysfunction, and myocardial infarction. Imaging studies reveal cerebral white matter hyperintensities, with delayed posthypoxic leukoencephalopathy or diffuse brain atrophy. Management of these patients requires the identification of accompanying drug ingestions, especially in the setting of intentional poisoning, fire-related toxic gas exposures, and inhalational injuries. Conventional therapy is limited to normobaric and hyperbaric oxygen, with no available antidotal therapy. Although hyperbaric oxygen significantly reduces the permanent neurological and affective effects of CO poisoning, a portion of survivors still have substantial morbidity. There has been some early success in therapies targeting the downstream inflammatory and oxidative effects of CO poisoning. New methods to directly target the toxic effect of CO, such as CO scavenging agents, are currently under development.

1 January 2013 in Redox Biology
Verified
Journal Article
Open access
SSSruti Shiva
Sruti Shiva
Nitrite, long considered a biologically inert metabolite of nitric oxide (NO) oxidation, is now accepted as a physiological storage pool of NO that can be reduced to bioactive NO in hypoxic conditions to mediate a spectrum of physiological responses in blood and tissue. This graphical review will provide a broad overview of the role of nitrite in physiology, focusing on its formation and reduction to NO as well as its regulation of the mitochondrion—an emerging subcellular target for its biological actions in tissues.

29 January 2013 in Biochemical Society Transactions
Verified
Journal Article
Closed access
PDF file
SZSergey Zharikov
Sergey Zharikov
SSSruti Shiva
Sruti Shiva
Circulating blood platelets contain small numbers of fully functional mitochondria. Accumulating evidence demonstrates that these mitochondria regulate the pro-thrombotic function of platelets through not only energy generation, but also redox signalling and the initiation of apoptosis. Beyond its regulation of haemostasis, platelet mitochondrial function has also traditionally been used to identify and study mitochondrial dysfunction in human disease, owing to the easy accessibility of platelets compared with other metabolically active tissues. In the present article, we provide a brief overview of what is currently known about the function of mitochondria in platelets and review how platelet mitochondria have been used to study mitochondrial function in human disease.

1 May 2014 in Blood
Verified
Journal Article
Open access
PDF file
NCNayra Cardenes
Nayra Cardenes
CCCatherine Corey
Catherine Corey
LGLisa Geary
Lisa Geary
SJShilpa Jain
Shilpa Jain
SZSergey Zharikov
Sergey Zharikov
SSSruti Shiva
Sruti Shiva
Key Points: Sickle cell patients show mitochondrial dysfunction (complex V inhibition, oxidant formation), which is associated with platelet activation. Complex V inhibition is induced by hemolysis and causes platelet activation, which is attenuated by mitochondrial therapeutics.

30 March 2017 in Hepatology
Verified
Journal Article
Closed access
PDF file
STSamer Tohme
Samer Tohme
HYHamza Yazdani
Hamza Yazdani
YLYao Liu
Yao Liu
PLPatricia Loughran
Patricia Loughran
DWDirk J. van der Windt
Dirk J. van der Windt
ATAllan Tsung
Allan Tsung